ÂÜÀòÂÒÂ×

Bernie Tobin is a seasoned executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as General Manager at Natera since September 2020, Bernie has a proven track record in managing operations and P&L, particularly within molecular diagnostics and precision medicine for autoimmune disorders. Previously, Bernie held leadership roles at Crescendo Bioscience as President, where oversight included a budget of $40 million and 160 direct reports. At Amgen, Bernie excelled in various capacities, including General Manager for Brazil and Global Integration Lead, managing large teams and budgets while fostering effective business strategies and commercial excellence across global markets. Bernie also contributed to Eli Lilly and Company as Global Marketing Lead, enhancing performance in major international markets. Educational achievements include an MBA in Marketing from Duke University's Fuqua School of Business and a BS in Public Service and Administration from Iowa State University.